SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,391.39 -363.66
( -0.47%)

Global Indices

Nasdaq

52,250.80 5.16
(0.01%)

Dow Jones

7,521.33 -8.87
(-0.12%)

Hang Seng

66,278.94 163.34
(0.25%)

Nikkei 225

10,722.03 136.12
(1.29%)

Forex

USD-INR

96.31 -0.12
(-0.13%)

EUR-INR

109.90 -0.27
(-0.25%)

GBP-INR

129.11 -0.56
(-0.43%)

JPY-INR

0.59 0.00
(-0.36%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

338.0498657

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

45.9

43218.36

EPS(TTM)

Face Value()

Div & Yield %

75.36

0.81

Back

aspira pathlab & diagnostics ltd

HDFC Bank consolidated net profit rises 18.37% in the June 2026 quarter

Jul 18,2026

Net profit of HDFC Bank rose 18.37% to Rs 19244.71 crore in the quarter ended June 2026 as against Rs 16257.91 crore during the previous quarter ended June 2025. Total Operating Income rose 3.67% to Rs 90575.33 crore in the quarter ended June 2026 as against Rs 87371.87 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Total Operating Income	90575.33	87371.87	4
OPM %	35.64	26.18	-
PBDT	27193.16	20849.83	30
PBT	27193.16	20849.83	30
NP	19244.71	16257.91	18

76,391.39 -363.66 ( -0.47%)

52,250.80 5.16 (0.01%)

7,521.33 -8.87 (-0.12%)

66,278.94 163.34 (0.25%)

10,722.03 136.12 (1.29%)

96.31 -0.12 (-0.13%)

109.90 -0.27 (-0.25%)

129.11 -0.56 (-0.43%)

0.59 0.00 (-0.36%)